tirzepatide jay campbell Tirzepatide vs. Semaglutide for Patients with Obesity: A Head-to-Head Trial https Products Jay Campbell Personally Uses

Limitations of the present study include the fact that there was only a single dose of treatment and also that there were not the same number of participants in each treatment group, with fewest in the severely impaired hepatic function group

It is not sold or described for weight management, diagnosis, treatment, or administration

+The benefit-risk balance remains in favour of using semaglutide for its approved indications (diabetes, obesity) for most patientsbut the ocular risk is something to monitor, especially in high-risk eyes

At Vive Ageless Weight Loss Center, our medical professionals customize GLP-1 therapies like Ozempic as part of a comprehensive, individualized weight-loss program